Joel U.
- Country
- France
- Department
- 250006: Service Ophtalmologie
Research Overview
Data & Insights
Has run more than one trial at 0 of 68 partner sites.
Specializations
Retinal Vascular Diseases
Therapeutic strategies targeting fluid accumulation and vascular leakage in the retina.
- Management of diabetic macular edema with sustained‑release corticosteroid implants
- Evaluation of anti‑VEGF agents for macular telangiectasia type 1
- Optimization of treatment regimens for retinal edema secondary to systemic disease
Clinical activity is centered at a dedicated ophthalmology service in Rouen.
Age‑Related Macular Degeneration
Interventions aimed at slowing disease progression and preserving visual function.
- Long‑term safety of the Port Delivery System for neovascular AMD
- Oral complement inhibition to reduce growth of geographic atrophy
- Assessment of novel pharmacologic agents for dry AMD
Focus includes both neovascular and atrophic disease phenotypes.
Gynecologic Oncology
Targeted and cytoreductive approaches for epithelial ovarian malignancies.
- Use of hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer
- Integration of surgical debulking strategies with systemic therapy
- Evaluation of treatment sequencing in fallopian‑tube and peritoneal ovarian cancers
Research supports multidisciplinary care pathways.
Gastro‑intestinal and Anal Oncology
Combined modality regimens for locally advanced and metastatic gastrointestinal tumors.
- Induction chemotherapy followed by chemoradiotherapy for anal squamous cell carcinoma
- Combination of trifluridine/tipiracil with anti‑angiogenic agents for metastatic oesophagogastric adenocarcinoma
- Assessment of disease‑free survival endpoints in high‑risk gastrointestinal cancers
Efforts aim to improve long‑term outcomes in aggressive disease settings.
Hormone‑Responsive Breast Cancer
Adjuvant strategies for estrogen‑receptor positive, HER2‑negative disease in older patients.
- Comparison of chemotherapy alone versus chemotherapy plus endocrine therapy
- Stratification by genomic grade to guide treatment intensity
- Evaluation of overall survival benefits in the elderly population
Research integrates molecular profiling with clinical decision‑making.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.